Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73


The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.

Philpot B, McNamara K, Dunbar JA.

Br J Gen Pract. 2012 Apr;62(597):180; author reply 180-1. doi: 10.3399/bjgp12X635994. No abstract available.


The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.

Brett T, Arnold-Reed D, Phan C, Cadden F, Walker W, Manea-Walley W, Mora N, Young J, Bulsara M.

Br J Gen Pract. 2012 Jan;62(594):e22-8. doi: 10.3399/bjgp12X616337.


EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.


Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study.

Brotons C, Soriano N, Moral I, Rodrigo MP, Kloppe P, Rodríguez AI, González ML, Ariño D, Orozco D, Buitrago F, Pepió JM, Borrás I; PREseAP study research team.

Rev Esp Cardiol. 2011 Jan;64(1):13-20. doi: 10.1016/j.recesp.2010.07.005. Epub 2010 Dec 30. Erratum in: Rev Esp Cardiol. 2011 Jun;64(6):544.


Cardiovascular absolute risk assessment -- a research journey in general practice.

Zwar N, Harris MF, Denney-Wilson E.

Aust Fam Physician. 2011 May;40(5):309.


Implementation of the NHS Health Checks programme: baseline assessment of risk factor recording in an urban culturally diverse setting.

Dalton AR, Bottle A, Okoro C, Majeed A, Millett C.

Fam Pract. 2011 Feb;28(1):34-40. doi: 10.1093/fampra/cmq068. Epub 2010 Aug 28.


Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk.

El Fakiri F, Bruijnzeels MA, Hoes AW.

Heart. 2006 Jun;92(6):741-5. Epub 2005 Oct 26.


Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.

Tocci G, Ferrucci A, Passerini J, Averna M, Bellotti P, Bruno G, Cosentino F, Crepaldi G, Giannattasio C, Modena MG, Nati G, Tiengo A, Trimarco B, Vanuzzo D, Volpe M.

High Blood Press Cardiovasc Prev. 2011 Jun 1;18(2):43-51. doi: 10.2165/11593420-000000000-00000.


Assessment and management of lifestyle risk factors in rural and urban general practices in Australia.

Passey M, Fanaian M, Lyle D, Harris MF.

Aust J Prim Health. 2010;16(1):81-6.


Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial.

Holt TA, Thorogood M, Griffiths F, Munday S, Friede T, Stables D.

Br J Gen Pract. 2010 Apr;60(573):e137-43. doi: 10.3399/bjgp10X483904.


Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

McCormack T, Harvey P, Gaunt R, Allgar V, Chipperfield R, Robinson P; IN-PRACTICE study.

Int J Clin Pract. 2010 Jul;64(8):1052-61. doi: 10.1111/j.1742-1241.2010.02429.x. Epub 2010 May 12.


Adherence to a guideline on cardiovascular prevention: a comparison between general practitioners and practice nurses.

Voogdt-Pruis HR, Van Ree JW, Gorgels AP, Beusmans GH.

Int J Nurs Stud. 2011 Jul;48(7):798-807. doi: 10.1016/j.ijnurstu.2010.11.008. Epub 2010 Dec 21.


Randomised controlled trial of additional lifestyle support for the reduction of cardiovascular disease risk through primary care in Stoke-on-Trent, UK.

Davey R, Cochrane T, Iqbal Z, Rajaratnam G, Chambers R, Mawby Y, Picariello L, Leese C, Ryder N.

Contemp Clin Trials. 2010 Jul;31(4):345-54. doi: 10.1016/j.cct.2010.04.002. Epub 2010 Apr 26.


Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial.

Voogdt-Pruis HR, Beusmans GH, Gorgels AP, Kester AD, Van Ree JW.

Br J Gen Pract. 2010 Jan;60(570):40-6. doi: 10.3399/bjgp10X482095.


Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice.

Keller H, Krones T, Becker A, Hirsch O, Sönnichsen AC, Popert U, Kaufmann-Kolle P, Rochon J, Wegscheider K, Baum E, Donner-Banzhoff N.

Eur J Prev Cardiol. 2012 Jun;19(3):322-9. doi: 10.1177/1741826711404502. Epub 2011 Mar 24.


Cardiovascular absolute risk assessment and management - engagement and outcomes in general practice patients.

Wan Q, Zwar N, Vagholkar S, Campbell T, Harris M.

Aust Fam Physician. 2010 Dec;39(12):954-8.


Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group.

Diabetes Care. 2003 Dec;26(12):3264-72.

Items per page

Supplemental Content

Write to the Help Desk